Connecticut Innovations Reports Record $51.4 Million in Q1 FY27 Venture Proceeds
Connecticut Innovations (CI) achieved a historic milestone in the first quarter of its 2027 fiscal year, generating $51.4 million in venture proceeds. This record-breaking performance was primarily driven by the successful initial public offering (IPO) of portfolio company Veradermics. During the quarter ending September 30, 2026, CI deployed approximately $15.6 million across 25 different companies and venture funds. The firm's investment strategy showed a significant tilt toward emerging sectors, with $5.7 million directed toward climate tech and $4.5 million toward technology, including AI. These investments successfully leveraged an additional $76.7 million in outside capital. Beyond financial transactions, CI's talent acquisition program facilitated 89 professional hires within its portfolio companies during the quarter.
Tickers: $MANE
Topics: economic growth investment performance IPO venture capital proceeds